Year archive

Active Biotech — 2014 filings

All 49 regulatory filings released by Active Biotech (ACTI) in 2014, sourced directly from the official regulator.

49 Filings

2014 Period

2014 filings (49)

Filing	Released	Lang
Active Biotechs nyemission om cirka 225 miljoner kronor övertecknad Share Issue/Capital Change	2014-12-29	Swedish
Active Biotech's rights issue of approximately SEK 225 million oversubscribed Capital/Financing Update	2014-12-29	English
Active Biotechs valberedning utsedd AGM Information	2014-12-09	Swedish
Active Biotech's election committee appointed AGM Information	2014-12-09	English
Prospekt avseende Active Biotechs nyemission offentliggjort Report Publication Announcement	2014-12-05	Swedish
Prospectus relating to Active Biotech's rights issue published Report Publication Announcement	2014-12-05	English
Extraordinary General Meeting of Active Biotech AB (publ) AGM Information	2014-12-01	English
Extra bolagsstämma i Active Biotech AB (publ) Capital/Financing Update	2014-12-01	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report 9M 2014	2014-11-05	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report 9M 2014	2014-11-05	English
Active Biotech AB: Notice of Extraordinary General Meeting of Shareholders AGM Information	2014-11-05	English
Active Biotech AB: Kallelse till extra bolagsstämma AGM Information	2014-11-05	Swedish
Teva och Active Biotech utvidgar det kliniska prövningsprogrammet för laquinimod med en ny studie i primärprogressiv MS och den första patienten är screenad för studien i Huntingtons sjukdom Regulatory Filings	2014-11-04	Swedish
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial Regulatory Filings	2014-11-04	English
Teva presenterar nya kliniska säkerhetsdata från RRMS-patienter som behandlats med laquinimod under två år eller längre på konferensen ACTRIMS-ECTRIMS Regulatory Filings	2014-09-12	Swedish
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting Regulatory Filings	2014-09-12	English
Active Biotechs partner Teva startar en klinisk studie med laquinimod i Huntingtons sjukdom Regulatory Filings	2014-08-14	Swedish
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease Regulatory Filings	2014-08-14	English
Interim / Quarterly Report 2014 Interim / Quarterly Report H2 2014	2014-08-07	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report H2 2014	2014-08-07	English
Active Biotech AB Delårsrapport januari - juni 2014 Interim / Quarterly Report H2 2014	2014-08-07	Swedish
Active Biotech AB Interim report January-June 2014 Interim / Quarterly Report H2 2014	2014-08-07	English
Active Biotech presents data on paquinimod at EULAR 2014 Regulatory Filings	2014-06-11	English
Active Biotech presenterar data för paquinimod på EULAR 2014 Regulatory Filings	2014-06-11	Swedish
Active Biotech to Present at Jefferies 2014 Healthcare Conference Report Publication Announcement	2014-06-03	English
Active Biotech presenterar på Jefferies 2014 Healthcare Conference Investor Presentation	2014-06-03	Swedish
Teva and Active Biotech to continue with the development of NERVENTRA® (laquinimod) for multiple sclerosis following confirmation of CHMP opinion Regulatory Filings	2014-05-23	English
Teva och Active Biotech fortsätter utvecklingen av NERVENTRA® (laquinimod) för multipel skleros efter bekräftat utlåtande från CHMP Regulatory Filings	2014-05-23	Swedish
Årsstämma i Active Biotech AB AGM Information	2014-05-16	Swedish
Annual General Meeting of Active Biotech AB AGM Information	2014-05-16	English
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-04-24	Swedish
Interim / Quarterly Report 2014 Interim / Quarterly Report Q1 2014	2014-04-24	English
Active Biotech AB Interim report January - March 2014 Interim / Quarterly Report Q1 2014	2014-04-24	English
Active Biotech AB Delårsrapport januari - mars 2014 Interim / Quarterly Report Q1 2014	2014-04-24	Swedish
Active Biotech - Notice of Annual General Meeting of Shareholders AGM Information	2014-04-14	English
Active Biotech - Kallelse till årsstämma AGM Information	2014-04-14	Swedish
Annual Report 2013 Active Biotech AB (publ) Report Publication Announcement	2014-04-07	English
Årsredovisning 2013 Active Biotech AB (publ) Report Publication Announcement	2014-04-07	Swedish
Annual Report 2014 Annual Report FY 2014	2014-04-07	Swedish
Change in the clinical development program for laquinimod Regulatory Filings	2014-02-19	English
Ändring i det kliniska utvecklingsprogrammet för laquinimod Regulatory Filings	2014-02-19	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report FY 2013	2014-02-13	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report FY 2013	2014-02-13	English
Active Biotech AB Year-end report January - December 2013 Interim / Quarterly Report FY 2013	2014-02-13	English
Active Biotech AB Bokslutsrapport januari - december 2013 Interim / Quarterly Report FY 2013	2014-02-13	Swedish
Teva and Active Biotech Remain Committed to the Development of NERVENTRA® (laquinimod) for Multiple Sclerosis Following the Negative Opinion from the EMA's CHMP Regulatory Filings	2014-01-24	English
Teva och Active Biotech fortsätter att med full kraft driva utvecklingen av NERVENTRA® (laquinimod) för behandling av multipel skleros efter negativ bedömning från EMA:s CHMP Regulatory Filings	2014-01-24	Swedish
Active Biotech to Present at the 32nd Annual J.P. Morgan Healthcare Conference Report Publication Announcement	2014-01-09	English
Active Biotech presenterar på 32nd Annual J.P. Morgan Healthcare Conference Investor Presentation	2014-01-09	Swedish

Filings by year

2026 11 filings
2025 41 filings
2024 45 filings
2023 32 filings
2022 42 filings
2021 48 filings
2020 41 filings
2019 45 filings
2018 38 filings
2017 33 filings
2016 40 filings
2015 40 filings
2014 49 filings
2013 58 filings
2012 58 filings
2011 56 filings
2010 62 filings
2009 55 filings
2008 28 filings
2007 8 filings